Resolution of Medical Issues through Products and Services
In relation to aging populations in advanced countries, in recent years the need has been growing to reduce healthcare costs and extend healthy lifespans. At the same time, the establishment of medical infrastructure is unable to keep pace with growing populations in emerging markets and developing countries, and some 400 million people around the world are not receiving necessary levels of healthcare*. Boosting access to healthcare services is therefore an issue.
Meanwhile, the Sustainable Development Goals (SDGs) set targets for human health and welfare, prompting growing expectations for global companies to undertake initiatives to resolve medical issues.
Under these conditions, the in vitro diagnostics (IVD) domain, which plays an important role in disease prevention, early detection and determining courses of treatment, is expected to contribute to a healthy society by creating new value and solving healthcare issues, including the three most deadly infectious diseases (HIV/AIDS, tuberculosis, malaria).
Sysmex believes the resolution of medical issues through its business activities and activities that improve access to healthcare contribute to social sustainability and will bolster corporate value through the creation of new technologies and markets.
* Source: WHO “Universal Health Coverage”
Since the time of our founding, Sysmex has expanded its product lineup and strengthened its services and support in response to testing needs, working to provide accurate test data swiftly. In recent years, we have been conducting research and development on gene testing and other advanced, high-value testing and diagnosis technologies that lead to early detection and treatment with a view to realizing personalized medicine. To boost access to healthcare in emerging markets and developing countries, we are promoting business activities aimed at raising local levels of healthcare by enhancing lab quality and promoting the training of healthcare professionals.
By leveraging the unique technologies we have cultivated to date, as well as our global network, we will continue to contribute toward the development of healthcare and the healthy lives of people.